24.3
항체 매개 면역 반응(antibody-mediated immune response)이라고도 알려진 체액성 면역 반응(humoral immune response)은 “체액(humor)”, 즉 혈액과 림프(lymph)와 같은 세포외액(extracellular flui…
- [강사] 다른 적응 면역 반응에서체액 면역은 면역계가 삼는 표적이 병원체로서세포 외액 순환하고 있는 것인데혈액과 림프가 포함됩니다박테리아와 같은 병원균의 침입은특정 백혈구인 B 세포가 감지하는데박테리아 표면의 특정 항원을 인식합니다일단 B 세포가 활성화되면증식을 통해 원형질 세포로 분화하며수백만 개의 항체를 분비합니다이들은 몸 전체에 여러 방어 메커니즘을 활성화시킵니다한 가지 방법으로, 병원체 표면에 항원을 결합하는 항체는병원체를 비활성화 또는 중화시킬 수 있으며숙주 세포에 대한 감염 능력을 방해하며 일어납니다또한 병원균을 옵소닌하거나 태그하여식세포에 의한 흡입과 파괴가 이어지며대식 세포 또는 호중구가 해당됩니다마지막으로, 항체는 보체계를 활성화시키며이는 단백질의 복합체로서병원균의 옵소닌 과정과 파괴를 한층 강화시킵니다병원균이 파괴되더라도일부 활성화된 B 세포는원형질 세포 대신에 기억 B 세포로 변합니다이러한 기억 B 세포는 계속해서감염이 사라진지 오래라도 소량의 항체를 생산합니다만약 동일 병원체가 몸에 진입하면이러한 순환 항체의 표적이 되어즉각적인 파괴를 단행합니다
View the full transcript and gain access to JoVE Core videos
Q1: What are the main defense mechanisms antibodies use to destroy pathogens?
Antibodies destroy pathogens through three primary mechanisms: neutralization, opsonization, and complement system activation. Neutralization occurs when antibodies bind to pathogen surfaces and interfere with their ability to infect host cells. Opsonization tags pathogens for destruction by phagocytes like macrophages and neutrophils. The complement system, a cascade of over 30 proteins, further enhances pathogen destruction and triggers inflammatory responses.
Q2: How do B cells recognize and respond to invading pathogens?
B cells detect pathogens by recognizing specific antigens on bacterial surfaces through their B cell receptors. Upon antigen binding and receiving a second signal from helper T cells or the antigen itself, B cells become activated and form germinal centers. In these centers, B cells proliferate and differentiate into plasma cells that secrete millions of antibodies, or into memory B cells that provide long-term immunity.
Q3: What is the difference between plasma cells and memory B cells?
Plasma cells are short-lived B cells that actively secrete large quantities of genetically identical antibodies circulating throughout the bloodstream. Memory B cells are long-lived cells that produce antibodies bound to their surface and enable rapid, stronger immune responses upon reexposure to the same pathogen. Memory B cells persist long after infection clears, providing lasting immunity.
Q4: Why do patients with antibody deficiencies suffer from frequent infections?
Patients with antibody deficiencies like hypogammaglobulinemia lack sufficient antibodies to neutralize, opsonize, or activate complement against pathogens. Without adequate antibody production, pathogens circulating in blood and lymph evade destruction, leading to frequent ear, sinus, pulmonary, and gastrointestinal infections. Infections by unusual pathogens become severe, and common pathogen infections are often recurrent.
Q5: How does the humoral immune response target pathogens in body fluids?
The humoral immune response targets pathogens circulating in extracellular fluids like blood and lymph. B cells detect specific antigens on pathogen surfaces and differentiate into plasma cells that secrete antibodies. These antibodies circulate throughout the body, binding to antigens and activating defense mechanisms including neutralization, opsonization, and complement system activation.
Q6: What role do memory B cells play in secondary immune responses?
Memory B cells persist long after initial infection and continue producing small amounts of antibody. When the same pathogen reenters the body, circulating antibodies from memory B cells immediately target it for destruction, enabling faster and stronger immune responses. This mechanism provides long-term protection against reinfection by previously encountered pathogens.
Q7: How does the complement system enhance pathogen destruction?
The complement system is a sequential cascade of over 30 proteins activated by antibodies binding to antigens. These proteins opsonize pathogens for destruction by macrophages and neutrophils, induce inflammatory responses that recruit additional immune cells, and promote lysis of pathogen membranes. This multi-step process significantly amplifies the antibody-mediated immune response.